ARTA
KITE

A.R.T. Advisors’s Kite Pharma, Inc. KITE Stock Holding History

A.R.T. Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-29,873
Closed -$3.1M – 1900
2017
Q2 		$3.1M Sell
29,873
-41,600
-58% -$3.39M 0.16% 145
2017
Q1 		$5.61M Buy
+71,473
New +$4.42M 0.26% 82
2016
Q4 		– Sell
-4,800
Closed -$268K – 1472
2016
Q3 		$268K Buy
+4,800
New +$267K 0.09% 383
2016
Q1 		– Sell
-7,058
Closed -$434K – 1842
2015
Q4 		$434K Buy
+7,058
New +$497K 0.02% 924
2015
Q2 		– Sell
-16,552
Closed -$954K – 1868
2015
Q1 		$954K Buy
16,552
+3,226
+24% +$216K 0.03% 676
2014
Q4 		$768K Buy
+13,326
New +$561K 0.03% 761

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

A.R.T. Advisors's KITE Position: Q3 2017 in Review

A.R.T. Advisors sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 29,873 shares — an estimated $3.1M sold.

A.R.T. Advisors first reported a position in KITE in Q4 2014 and held it in 6 quarters. The position peaked at $5.61M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • A.R.T. Advisors reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 29,873 Kite Pharma, Inc. shares in Q3 2017, an estimated $3.1M.
  • A.R.T. Advisors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 6 quarters.
  • A.R.T. Advisors's Kite Pharma, Inc. position peaked at $5.61M in Q1 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.